Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis

Author:

Okumura Hiroyuki,Fukushima Ayako,Taieb Vanessa,Shoji Shingo,English Marci

Funder

Astellas Pharma, Inc

Astellas Pharma Global Development, Inc.

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference18 articles.

1. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA);McDonald;Clin Infect Dis,2018

2. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis;Beinortas;Lancet Infect Dis,2018

3. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence;Vardakas;Int J Antimicrob Agents,2012

4. Economic burden of Clostridium difficile-associated diarrhoea: a cost-of-illness study from a German tertiary care hospital;Heimann;Infection,2015

5. Consequences of Clostridium difficile infection: understanding the healthcare burden;Bouza;Clin Microbiol Infect,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3